Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.65 |
| ▸ | BRD2 | P25440 | 1/20 | 0.65 |
| ▸ | LMNA | P02545 | 3/20 | 0.54 |
| ▸ | CA12 | O43570 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
| ▸ | CA3 | P07451 | 1/20 | 0.54 |
| ▸ | CA4 | P22748 | 1/20 | 0.54 |
| ▸ | CA6 | P23280 | 1/20 | 0.54 |
| ▸ | CA5A | P35218 | 1/20 | 0.54 |
| ▸ | CA7 | P43166 | 1/20 | 0.54 |
| ▸ | CA9 | Q16790 | 1/20 | 0.54 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.54 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylpyrrolidone SCHEMBL28231789 | 0.92 | BRD4 (0.55) | BRD4BRD2LMNACA12CA1 | |
| Methylpyrrolidone SCHEMBL27799421 | 0.88 | BRD4 (0.77) | BRD4BRD2LMNACA12CA1 | |
| Methylpyrrolidone SCHEMBL6251574 | 0.86 | BRD4 (0.74) | BRD4BRD2LMNACA12CA1 | |
| Methylpyrrolidone SCHEMBL3004368 | 0.84 | BRD4 (0.77) | BRD4BRD2LMNACA12CA1 | |
| Methylpyrrolidone SCHEMBL28229116 | 0.84 | BRD4 (0.77) | BRD4BRD2LMNACA12CA1 | |
| Methylpyrrolidone SCHEMBL28252843 | 0.82 | CA1 (0.57) | BRD4BRD2LMNACA12CA1 | |
| Methylpyrrolidone SCHEMBL10701586 | 0.81 | BRD4 (0.81) | BRD4BRD2LMNACA12CA1 | |
| Methylpyrrolidone SCHEMBL2243830 | 0.81 | BRD4 (0.81) | BRD4BRD2LMNACA12CA1 | |
| Methylpyrrolidone SCHEMBL7170191 | 0.81 | — | — | |
| Methylpyrrolidone SCHEMBL1368701 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113314746-B | Cross-linked functionalized polyvinyl alcohol anion exchange membrane and preparation method thereof | 温州黑鹰网络科技有限公司 | 2022-09-09 | — | — | CN | claimed |
| CN-114874621-A | Low-dielectric-conductivity thermal polyimide film and preparation method thereof | 纳电(深圳)材料科技有限公司 | 2022-08-09 | — | — | CN | claimed |
| CN-113314746-A | Cross-linked functionalized polyvinyl alcohol anion exchange membrane and preparation method thereof | 温州黑鹰网络科技有限公司 | 2021-08-27 | — | — | CN | claimed |
| WO-2015137914-A1 | METHODS FOR PRODUCING NYLON 7 | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2015-09-17 | — | — | WO | claimed |
| US-5003103-A | Decarboxylation, chlorodenitration, catalysis | OCCIDENTAL CHEMICAL CORPORATION (US) | 1991-03-26 | — | — | US | claimed |
| CN-117545757-A | 5-oxo-pyrido [2,3-d ] pyridazin-6 (5H) -ylacetamides | 詹森药业有限公司 | 2024-02-09 | — | — | CN | disclosed |
| US-11786534-B2 | Substituted pyrrolo[2,3-d]pyrimidines as EGFR inhibitors | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2023-10-17 | — | — | US | disclosed |
| EP-4153556-A1 | METHOD FOR PREPARING ACRYLIC ACID FROM BETA-PROPIOLACTONE | Commissariat à l'Energie Atomique et aux Energies Alternatives (FR) | 2023-03-29 | — | — | EP | disclosed |
| CN-112375010-B | Novel diamine, polyimide and polyimide film | 浙江中科玖源新材料有限公司 | 2023-03-10 | — | — | CN | disclosed |
| CN-113314746-B | Cross-linked functionalized polyvinyl alcohol anion exchange membrane and preparation method thereof | 温州黑鹰网络科技有限公司 | 2022-09-09 | — | — | CN | disclosed |
| US-11384121-B2 | Creation of peptide-based anti-tumor agent | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2022-07-12 | — | — | US | disclosed |
| WO-2021233839-A1 | METHOD FOR PREPARING ACRYLIC ACID FROM β-PROPIOLACTONE | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2021-11-25 | — | — | WO | disclosed |
| EP-0358395-A2 | Aromatic imide polymer fiber-reinforced prepreg and cured resinous laminate material derived from same | UBE INDUSTRIES, LTD. (JP) | 1990-03-14 | — | — | EP | disclosed |
| US-4801502-A | SERRATED FIBERS-WOOL LIKE | CHEMIEFASER LENZING AKTIENGESELLSCHAFT (AT) | 1989-01-31 | — | — | US | disclosed |
| US-4707400-A | WATERPROOFING, PERMEABILITY, COATINGS, FABRICS, POLYURETHANES, ACRYLIC ACID POLYMER | BURLINGTON INDUSTRIES, INC. (US) | 1987-11-17 | — | — | US | disclosed |
| US-4598091-A | (1,2-diphenyl)-ethylenediamine)-platinum (II) complex compounds | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1986-07-01 | — | — | US | disclosed |
| EP-0000924-B1 | HETEROCYCLIC PHENYL ETHERS AND PROCESS FOR THEIR PREPARATION | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-04-29 | — | — | EP | disclosed |
| US-4145532-A | TERTIARY AMINE OXIDE SOLVENT | AKZONA INCORPORATED (US) | 1979-03-20 | — | — | US | disclosed |
| EP-0000924-A1 | Heterocyclic phenyl ethers and process for their preparation | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-03-07 | — | — | EP | disclosed |
| US-4076694-A | FROM A POLYISOCYANATE AND A SUBSTITUTED CYCLIC CARBOXYLIC ACID ANHYDRIDE | BAYER AKTIENGESELLSCHAFT (DT) | 1978-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11384121-B2 | Creation of peptide-based anti-tumor agent | NGLY1, VIP, ETF1 | BRD4 3134/4885BRD2 4559/4885LMNA 3049/4885 |
| US-11786534-B2 | Substituted pyrrolo[2,3-d]pyrimidines as EGFR inhibitors | EGFR, ERBB2, ERBB3 | BRD4 618/4885BRD2 909/4885LMNA 4883/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.